• Cannabics Concludes Pre-Clinical Study on Human Biopsies americanpharmaceuticalreview
    November 19, 2020
    Cannabics Pharmaceuticals has completed a pre-clinical study using its proprietary and novel RCC-33 formulation on human biopsies, obtained under a Helsinki Committee approved protocol.
PharmaSources Customer Service